The size of the biopharmaceuticals market will power at a compound annual growth rate of 7.1% by the end of this decade, to touch a value of USD 720.8 billion by 2030. This significant growth of the industry is due to the surging prevalence of chronic diseases, like cancer, diabetes and cardiovascular ailments. Moreover, the increasing geriatric population and the … Continua a leggere→